Current Liabilities تغییر دادن تاریخ
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
Amgen USD 18.39B 1.44B 2023-12
Baxter International USD 6.5B 294M 2023-12
Cara Therapeutics USD 22.88M 2.58M 2023-09
Cytokinetics USD 102.68M 24.96M 2023-12
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Intrexon USD 32.88M 2.1M 2023-09
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
MannKind USD 104.12M 7.75M 2023-12
Minerva Neurosciences USD 3.35M 1.44M 2023-09
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Peregrine Pharmaceuticals USD 76.94M 12.88M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Rigel Pharmaceuticals USD 48.27M 4.25M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12
Vanda Pharmaceuticals USD 87.4M 6.4M 2023-06



Halozyme Therapeutics بدهی های جاری - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.